ATAI Life Sciences
ATAI
ATAI
97 hedge funds and large institutions have $26.3M invested in ATAI Life Sciences in 2023 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 24 increasing their positions, 25 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
7% less funds holding
Funds holding: 104 → 97 (-7)
15% less capital invested
Capital invested by funds: $31.1M → $26.3M (-$4.82M)
37% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 19
Holders
97
Holding in Top 10
1
Calls
$1.09M
Puts
$148K
Top Buyers
| 1 | +$694K | |
| 2 | +$644K | |
| 3 | +$583K | |
| 4 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
+$506K |
| 5 |
Rafferty Asset Management
New York
|
+$299K |
Top Sellers
| 1 | -$1.74M | |
| 2 | -$1.04M | |
| 3 | -$810K | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$791K |
| 5 |
Cerity Partners
New York
|
-$721K |